← Back to Search


High-Flow Nasal Cannula for Cardiac Surgery

Led By Robert E Freundlich, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up72 hours
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will compare the reintubation rates and outcomes of patients treated with high-flow nasal cannula oxygen therapy versus those treated with standard care.

Eligible Conditions
  • Intubation
  • Cardiac Surgery


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reintubation within 48 hours of extubation
Secondary outcome measures
Perinatal death
Hospital length of stay
In-hospital mortality
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High Flow Nasal Canula Oxygen TherapyExperimental Treatment1 Intervention
Participants will be assigned post extubation physician order set which recommends the administration of oxygen therapy via HFNC. HFNC is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.
Group II: Provider Choice Standard CareActive Control1 Intervention
Participants be assigned standard provider choice of standard care therapy physician order set.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
832 Previous Clinical Trials
654,526 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,766 Previous Clinical Trials
47,260,284 Total Patients Enrolled
Robert E Freundlich, MDPrincipal InvestigatorVanderbilt University Medical Center

Media Library

Provider choice standard care order set (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04782817 — N/A
Intubation Research Study Groups: Provider Choice Standard Care, High Flow Nasal Canula Oxygen Therapy
Intubation Clinical Trial 2023: Provider choice standard care order set Highlights & Side Effects. Trial Name: NCT04782817 — N/A
Provider choice standard care order set (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04782817 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of enrollees for this research endeavor?

"Yes, the information on clinicaltrials.gov attests to this research being actively looking for participants. It was published on November 1st 2021 and most recently updated on November 2nd 2022; 3192 subjects are needed at a single medical facility."

Answered by AI

Are applications for this research program currently being accepted?

"Affirmative. Evidenced by clinicaltrials.gov, this medical trial is presently looking for participants. It was first advertised on November 1st 2021 and has been recently updated on November 2nd 2022; the aim being to recruit 3192 individuals from a single clinic."

Answered by AI
Recent research and studies
~1463 spots leftby Nov 2025